Buzz
Delta Plus, a mutation derived from the Delta variant, has recently emerged as a new COVID-19 strain grabbing headlines. (Lambda, another previously identified variant, is also gaining attention.) However, there's no need for heightened alarm: Delta remains the primary concern.
How do Delta and Delta Plus differ?
Delta is a highly transmissible coronavirus strain rapidly becoming the dominant variant globally. It spreads as easily as chickenpox and far more efficiently than common colds or the flu. Due to its heightened contagiousness, previous measures effective against the original COVID strain are insufficient against Delta. Increased vaccination rates and stricter adherence to safety protocols like mask-wearing are essential to combat this more infectious virus.
Delta Plus refers to a Delta variant featuring an additional mutation. This specific mutation was previously identified in the Alpha variant, which circulated earlier this year, as reported by the Washington Post. In June, Reuters highlighted that this new mutation could potentially enhance the virus's ability to evade detection and destruction by the immune system.
It remains uncertain whether vaccines are less effective against Delta Plus compared to Delta. However, studies confirm that a single dose of the Pfizer vaccine offers reduced protection against Delta versus the original COVID strain, though a full two-dose regimen remains effective.
So, what exactly is Lambda?
The World Health Organization classifies Lambda as a “variant of interest,” placing it below “variants of concern” such as Delta in terms of urgency.
Lambda has recently gained attention, largely due to the heightened focus on Delta Plus. However, there’s no significant new threat associated with it. A recent study indicated that the Sinovac/CoronaVac vaccine might offer limited protection against Lambda, though this vaccine was already noted to be less effective against certain variants compared to those used in the U.S.
Why are new variants constantly making headlines?
With vaccination rates still insufficient, the virus finds ample space to thrive, replicate, and mutate—each unvaccinated individual serves as a potential host and breeding ground. (Most vaccinated individuals remain immune to the virus, at least for now.)
Had we successfully controlled COVID-19 through masks and distancing in early 2020, the virus might not have had the chance to diversify into numerous variants. Similarly, faster global vaccination efforts—not just in the U.S.—could have limited the virus's opportunities to evolve.
Evolution dictates that more successful variants outpace their less transmissible counterparts. Alpha surged and became dominant, and now Delta is following suit. As long as the virus has hosts to replicate in and pathways to spread, this cycle will persist.
Vaccination remains our strongest tool to establish population-wide immunity, though additional measures like wearing masks and avoiding crowded indoor spaces are crucial. Vaccines offer more durable and effective immunity compared to natural infection, underscoring the importance of getting vaccinated.
